Share Market California’s highest court rules for Gilead, says drugmakers don’t have ’duty to innovate’ by jmpwes August 3, 2026 written by jmpwes August 3, 2026 California’s highest court rules for Gilead, says drugmakers don’t have ’duty to innovate’ Source link 0 comment 0 FacebookTwitterPinterestEmail jmpwes previous post Facing a severe cash crunch, Bitcoin miner Sphere 3D quietly prepares to dilute its shareholders by a staggering 50% next post UBS Faces $125 Million FinCEN Penalty in Four-Regulator AML Case Related Posts Australia’s Qantas to exit Jetstar Japan in $52... August 3, 2026 Palantir lifts annual revenue forecast as data analytics... August 3, 2026 Trump blasts Exxon, Chevron for making ’too much... August 3, 2026 U.S. Treasury raises Q3 borrowing estimate to $739B August 3, 2026 Apple launches new legal challenge to UK attempt... August 3, 2026 Exclusive-Citi hires Bank of America’s Rohan Sen to... August 3, 2026 Leave a Comment Cancel Reply Save my name, email, and website in this browser for the next time I comment.